Targeting a cytokine pathway may offer a way to inhibit breast cancer cell survival and metastasis, study suggests.
News: August, 2014
Vanderbilt-Ingram Cancer Center and the American Cancer Society are now offering free makeover classes monthly for cancer patients.
by Dagny Stuart Colorectal cancer is one of the leading causes of death among populations around the world. While diet, physical activity and other lifestyle factors can influence the risk of developing the disease, hereditary factors also play an important role. Genetic factors identified to date explain only a small fraction of colorectal cancer (CRC), […]
by Dagny Stuart Charlie Haller had never smoked or used chewing tobacco and wasn’t a heavy drinker, so the 41-year-old Lyles, Tennessee, man wasn’t thinking about cancer when a mass developed on the side of his neck. His primary care physician, however, immediately referred him to a specialist and a biopsy revealed a form of […]
by Leigh MacMillan The protein MTBP is important for growth and survival of triple negative breast cancer (TNBC) – a clinically aggressive subtype of breast cancer that is commonly resistant to targeted therapeutics – Vanderbilt investigators have discovered. Using data from The Cancer Genome Atlas, Christine Eischen, Ph.D., MSTP student Brian Grieb, Ph.D., and colleagues […]
by Dagny Stuart Two Vanderbilt-Ingram Cancer Center investigators have received multi-year breast cancer research grants from the Susan G. Komen for the Cure Breast Cancer Foundation. Justin Balko, Ph.D., Pharm.D., research assistant professor of Medicine, won support for his research project which will use molecular profiling to prioritize adjuvant targeted therapy for triple negative breast […]